Academic literature on the topic 'Drug Resistance'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drug Resistance.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drug Resistance"

1

K, Tiwari. "Drug Resistance: Challenges and Updates." Journal of Natural & Ayurvedic Medicine 3, no. 3 (2019): 1–2. http://dx.doi.org/10.23880/jonam-16000196.

Full text
Abstract:
Use of antibiotics increased dramatically in last two decades. To cure most of the diseases broad spectrum antibiotics given. Human society and healthcare is going in wrong direction. One way the pharmaceutical companies are making huge money from it. The other way around is the overuse of these antibiotics, by patients knowing or unknowingly, not only making pathogens adapted but also the normal flora organisms becoming pathogens in coming future? Present article highlight the issues and possible solution of the present scenario.
APA, Harvard, Vancouver, ISO, and other styles
2

T.V., Sowjanya* B. Akhila N. Ahalya T. Sai Ram T. Maneesha V. Pavithra. "Drug Resistance In Various Disorders." International Journal in Pharmaceutical Sciences 2, no. 2 (2024): 558–64. https://doi.org/10.5281/zenodo.10684813.

Full text
Abstract:
Drug resistance is the ability of microorganisms, such as bacteria, viruses, or parasites, to withstand the effects of drugs that were intended to kill or inhibit their growth. In developed countries, drug resistance is the primary cause of death, the burden of infectious diseases is comparatively greater, and patients with a resistance are less likely to be able to afford secondary line treatments, which typically have more complex regimens than first line drugs. Nowadays, antibiotic resistance is increasing. Some of the common drug resistances like Bacteria, Cancer, Diabetes, Leprosy, and HI
APA, Harvard, Vancouver, ISO, and other styles
3

Singh, Amresh Kumar. "Resistance patterns and trends of extensively drug-resistant tuberculosis: 5-year experience." Journal of Microbiology and Infectious Diseases 03, no. 04 (2013): 169–75. http://dx.doi.org/10.5799/ahinjs.02.2013.04.0103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dyary, Hiewa Othman. "Veterinary Anthelmintics and Anthelmintic Drug Resistance." Journal of Zankoy Sulaimani - Part A 18, no. 1 (2015): 191–206. http://dx.doi.org/10.17656/jzs.10463.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Çelik, Cem. "Increasing antimicrobial resistance in nosocomial pathogens; multidrug-resistant extensively drug-resistant and pandrug-resistant Acinetobacter baumannii." Journal of Microbiology and Infectious Diseases 4, no. 1 (2014): 7–12. http://dx.doi.org/10.5799/ahinjs.02.2014.01.0116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Xiaoping, Zhang, and Yu Xiangmin. "Research Progress on Drug-Resistant Bacteria." International Journal of Sciences Volume 8, no. 2019-06 (2019): 1–5. https://doi.org/10.5281/zenodo.3350755.

Full text
Abstract:
More and more microorganisms have developed drug resistance with the use of antibiotics, and some microorganisms have multi-drug resistance. Therefore, bacterial resistant antibiotic is a serious problem to treating infectious diseases in recent years all over the world. This paper briefly reviews the research progress of bacterial resistance mechanisms all over the world, and provides theoretical basis for exploring effective prevention measures and rational use antibiotics in clinical.Read Complete Article at ijSciences: V82019052079 AND DOI: http://dx.doi.org/10.18483/ijSci.2079
APA, Harvard, Vancouver, ISO, and other styles
7

Giaccone, Giuseppe, and Herbert M. Pinedo. "Drug Resistance." Oncologist 1, no. 1-2 (1996): 82–87. http://dx.doi.org/10.1634/theoncologist.1-1-82.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hochhauser, D., and A. L. Harris. "Drug resistance." British Medical Bulletin 47, no. 1 (1991): 178–96. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072454.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Prichard, R. K. "Drug resistance." International Journal for Parasitology 29, no. 1 (1999): 137–38. http://dx.doi.org/10.1016/s0020-7519(98)00191-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Texidó, Gemma, and Jürgen Moll. "Drug resistance." Drug Discovery Today: Technologies 11 (March 2014): 1–3. http://dx.doi.org/10.1016/j.ddtec.2014.03.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Drug Resistance"

1

Abate, Getahun. "Drug resistance in mycobacterium tuberculosis /." Stockholm, 1999. http://diss.kib.ki.se/1999/91-628-3833-4/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Marijani, Theresia. "Modelling drug resistance in malaria." Thesis, Stellenbosch : University of Stellenbosch, 2009. http://hdl.handle.net/10019.1/4063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Johnson, Rabia. "Understanding the mechanisms of drug resistance in enhancing rapid molecular detection of drug resistance in Mycobacterium tuberculosis." Thesis, Link to the online version, 2007. http://hdl.handle.net/10019.1/1265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tam, Stanton Sui Yin. "Anticancer Drug Combinations to Overcome Drug Resistance in Breast Cancer." Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/27733.

Full text
Abstract:
For triple negative breast cancer (TNBC) patients, taxanes are the mainstays of chemotherapy but remain susceptible to resistance. Combination therapy of paclitaxel/docetaxel and tyrosine kinase inhibitors (TKIs) improves overall response rates in TNBC patients. Ixabepilone, mechanistically similar to taxanes, shows efficacy in TNBCs refractory to paclitaxel/docetaxel. Yet, there is a lack of studies on ixabepilone-TKI combinations. The first aim was to investigate the efficacy of these combinations in docetaxel-resistant MDA-MB-231 (TXT) cells and parental non-resistant MDA-MB-231 (231C) cell
APA, Harvard, Vancouver, ISO, and other styles
5

Abrahem, Abrahem F. "Mechanisms of drug resistance in malaria." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0033/MQ50704.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Scott, F. M. "Drug resistance mechanisms in multiple myeloma." Thesis, University of Edinburgh, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.661665.

Full text
Abstract:
The aim of this thesis was to investigate expression of putative drug resistance markers in myeloma both by examining clinical material and through the development of a xenograft model. Pgp expression was examined in 57 samples from 37 patients with myeloma. Of 23 samples at presentation and 37 at relapse, 7 and 26 respectively were Pgp positive. A myeloma xenograft model was established to examine the acute effects of cytotoxic drugs on the expression of "classical" drug resistance markers and genes involved in regulation of apoptosis. The untreated xenografts were Pgp negative, expressed low
APA, Harvard, Vancouver, ISO, and other styles
7

Pongtavornpinyo, Wirichada. "Mathematical modelling of antimalarial drug resistance." Thesis, University of Liverpool, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.428249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wildridge, David. "Metabolism and drug resistance in Trypanosomatids." Thesis, University of Glasgow, 2012. http://theses.gla.ac.uk/3622/.

Full text
Abstract:
The principle aim of this project is the investigation of metabolism and mechanisms of pentamidine resistance in trypanosomatids. An understanding of these mechanisms may allow the development of novel drugs to treat Leishmaniasis and human African trypanosomiasis (HAT), caused by the protozoan parasites Leishmania spp and Trypanosoma brucei. In this study a pentamidine resistance L. mexicana promastigote cell line was generated in vitro. This cell line was 20-fold resistant to pentamidine when compared to the parental wild type cells. Furthermore, these lines were cross resistant to other dia
APA, Harvard, Vancouver, ISO, and other styles
9

Doherty, Catherine Jean. "Drug resistance mechanisms in multiple myeloma." Thesis, University of Edinburgh, 1997. http://hdl.handle.net/1842/22154.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

ROMANO, GABRIELE. "Molecular mechanisms of cancer drug resistance." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2015. http://hdl.handle.net/10281/93577.

Full text
Abstract:
Colorectal cancer (CRC) is one of the most prevalent and incident cancers worldwide and it has become soon an important public health issue. Although surgery represents the principal curative treatment, chemotherapy is one of the most important tools currently available for the treatment of CRC. 5-fluorouracil (5FU) is the chemotherapeutic agent of election for CRC treatment. Two main problems affect the outcome of cancer chemotherapy: the use of poorly specific drugs and, in a high percentage of patients, the lack of response due to drug resistance, seen as a major obstacle to improve the ove
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Drug Resistance"

1

Hait, William N., ed. Drug Resistance. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1267-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Imperial Cancer Research Fund (Great Britain). Drug resistance. Edited by Stark, George R. (George Robert), 1933- and Calvert H. Published for the Imperial Cancer Research Fund by Oxford University Press, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

N, Hait William, ed. Drug resistance. Kluwer Academic Publishers, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Baiocchi, Marta, ed. Cancer Drug Resistance. Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2513-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mayers, Douglas L., Jack D. Sobel, Marc Ouellette, Keith S. Kaye, and Dror Marchaim, eds. Antimicrobial Drug Resistance. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46718-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Teicher, Beverly A., ed. Cancer Drug Resistance. Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-035-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Goldstein, Lori J., and Robert F. Ozols, eds. Anticancer Drug Resistance. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2632-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mayers, Douglas L., Jack D. Sobel, Marc Ouellette, Keith S. Kaye, and Dror Marchaim, eds. Antimicrobial Drug Resistance. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47266-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mayers, Douglas L., ed. Antimicrobial Drug Resistance. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-595-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mayers, Douglas L., ed. Antimicrobial Drug Resistance. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-180-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Drug Resistance"

1

Saez, S. "Drug Resistance." In Endocrine Therapy of Breast Cancer III. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-74504-1_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Bo. "Drug Resistance." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-27841-9_1739-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tomasetti, Cristian. "Drug Resistance." In A Systems Biology Approach to Blood. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-2095-2_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tew, Kenneth D. "Drug Resistance." In Basic Science of Cancer. Current Medicine Group, 2000. http://dx.doi.org/10.1007/978-1-4684-8437-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tu, Shi-Ming. "Drug Resistance." In Cancer Treatment and Research. Springer US, 2010. http://dx.doi.org/10.1007/978-1-4419-5968-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wang, Bo. "Drug Resistance." In Encyclopedia of Cancer. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-46875-3_1739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mounsey, Kate E., Robert J. Harvey, and Bart J. Currie. "Drug Resistance." In Scabies. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-26070-4_27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Weber, Georg F. "Drug Resistance." In Molecular Therapies of Cancer. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-13278-5_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ashraf, Saima, Nabila Bashir, Nadia Rashid, et al. "Introduction to Drugs, Drug Targets and Drug Resistance." In Biochemistry of Drug Resistance. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-76320-6_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ford, James M., Jin-Ming Yang, and William N. Hait. "P-Glycoprotein-Mediated Multidrug Resistance: Experimental and Clinical Strategies for its Reversal." In Drug Resistance. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1267-3_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Drug Resistance"

1

Sarkpa, Eastgar Garmonee, and Liang Xiao. "Knowledge Graphs for Drug Resistance Data Representation." In 2024 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2024. https://doi.org/10.1109/bibm62325.2024.10822289.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pompa, Marcello, Dániel András Drexler, Simona Panunzi, et al. "Modeling the development of drug resistance during chemotherapy treatment." In 2024 IEEE 63rd Conference on Decision and Control (CDC). IEEE, 2024. https://doi.org/10.1109/cdc56724.2024.10886423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Asnaashari, Tina Ghodsi, and Young Hwan Chang. "Optimal drug treatment for reducing long-term drug resistance." In 2022 IEEE 61st Conference on Decision and Control (CDC). IEEE, 2022. http://dx.doi.org/10.1109/cdc51059.2022.9992804.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Khamenehfar, Avid, Ji Liu, Jia Cai, et al. "Drug Accumulation Into Single Drug-Sensitive and Drug-Resistant Prostate Cancer Cells Conducted on the Single Cell Bioanalyzer." In ASME 2014 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/imece2014-36166.

Full text
Abstract:
Multidrug resistance (MDR) occurs in prostate cancer, and this happens when the cancer cells resist chemotherapeutic drugs by pumping them out of the cells. MDR inhibitors such as cyclosporin A (CsA) can stop the pumping and enhance the drugs accumulated in the cells. The cellular drug accumulation is monitored using a microfluidic chip mounted on a single cell bioanalyzer. This equipment has been developed to measure accumulation of drugs such as doxorubicin (DOX) and fluorescently labeled paclitaxel (PTX) in single prostate cancer cells. The inhibition of drug efflux on the same prostate cel
APA, Harvard, Vancouver, ISO, and other styles
5

Ayati, Marzieh, Golnaz Taheri, Shahriar Arab, Limsoon Wong, and Changiz Eslahchi. "Overcoming drug resistance by co-targeting." In 2010 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2010. http://dx.doi.org/10.1109/bibm.2010.5706562.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bumin, Aysegul, Megan Shah, Kejun Huang, and Tamer Kahveci. "Vulture: VULnerabilities in impuTing drUg REsistance." In BCB '23: 14th ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics. ACM, 2023. http://dx.doi.org/10.1145/3584371.3612993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shurbeska, Boneva, Jasmina Nikolovska, Vladimir Mitrevski, et al. "Following the resistance pattern of mycobacterium tuberculosis." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24029s.

Full text
Abstract:
Background: Tuberculosis (TB) accounts for over 40% of all mortality cases from communicable diseases in Europe.Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and rifampicin, the 2 most powerful anti-TB drugs. 30 countries worldwide are classified as high multi drug resistant (MDR) TB burden countries, nine are in the European Region. The emergence of combined resistance to rifampicin and isoniazid (MDR-TB) is a matter of global concern. Methods and Objectives: Over a period of 10 years we examined patient specimens for TB. Culture-positive samples were subje
APA, Harvard, Vancouver, ISO, and other styles
8

Sallum, Ulysses W., Xiang Zheng, Sarika Verma, and Tayyaba Hasan. "Exploiting bacterial drug resistance: a single construct for the diagnosis and treatment of drug resistant infections." In 12th World Congress of the International Photodynamic Association, edited by David H. Kessel. SPIE, 2009. http://dx.doi.org/10.1117/12.828202.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Casagrande, Anne-Sophie, Florence Mahe, Vin Kotraiah, Matt Pando, and Laurent Desire. "Abstract 4860: Identification of novel epitopes, drug resistance markers and drug resistance mechanism using alternative splicing studies." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4860.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Taitt, Chris Rowe, Tomasz Leski, David Stenger, et al. "Antimicrobial resistance determinant microarray for analysis of multi-drug resistant isolates." In SPIE Defense, Security, and Sensing. SPIE, 2012. http://dx.doi.org/10.1117/12.924569.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Drug Resistance"

1

DeClerck, Yves A. Environment-Mediated Drug Resistance in Neuroblastoma. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada591172.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

DeClerck, Yves A. Environment-Mediated Drug Resistance in Neuroblastoma. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada616252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Perelson, A. S., B. Goldstein, and B. T. Korber. Emerging pathogens: Dynamics, mutation and drug resistance. Office of Scientific and Technical Information (OSTI), 1997. http://dx.doi.org/10.2172/534529.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hiscott, John. Oncolytic Virotherapy Targeting Lung Cancer Drug Resistance. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada589848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kanja, Claire, and Sarah Bunn. Drug Therapies for COVID-19. Parliamentary Office of Science and Technology, 2022. http://dx.doi.org/10.58248/rr80.

Full text
Abstract:
Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.
APA, Harvard, Vancouver, ISO, and other styles
6

Shen, Youqing, Maciej Radosz, and William J. Murdoch. Breast Cancer-Targeted Nuclear Drug Delivery Overcoming Drug Resistance for Breast Cancer Chemotherapy. Defense Technical Information Center, 2011. http://dx.doi.org/10.21236/ada559246.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kennedy, Katherine A. Physiological Stree-Induced Drug Resistance and Its Reversal. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada398214.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kennedy, Katherine A. Physiological Stress-Induced Drug Resistance and Its Reversal. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada408700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kennedy, Katherine. Physiological Stress-Induced Drug Resistance and Its Reversal. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada383040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kennedy, Katherine. Physiological Stress-Induced Drug Resistance and its Reversal. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada474449.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!